Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Endeavour Silver Corp (EXK) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

Endeavour Silver CorpTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Endeavour Silver Corp vs Kymera Therapeutics Inc. Common Stock — how do they compare? Endeavour Silver Corp trades at $8 (market cap $2.32B), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 3.8× Endeavour Silver Corp's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Endeavour Silver Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 26 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

EXKKYMR
Market Cap
$2.32B$8.88B
Volume
8,976,4891,028,790
Sector
Basic MaterialsHealth
52-Week High
$14.12$127.31
52-Week Low
$7.07$55.80
Typical Hold Time
26 Days0 Days
Enterprise Value
$2.32B$8.27B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Endeavour Silver Corp

Endeavour Silver (EXK) trades at $8.24, down 3.51% today amid bearish technical signals. The company shows improving fundamentals with Q1 2026 earnings beating expectations and strong revenue growth projected for 2026. Recent news highlights operational progress at Terronera and Kolpa mines, though mechanical issues at Guanacevi and past blockades present challenges. Analyst sentiment remains predominantly bullish with 78.57% buy ratings.

EXK presents a growth story with expanding production capacity but faces execution risks. The stock's valuation appears elevated with a P/E of 39.15, requiring continued operational success to justify. Near-term catalysts include Terronera mine ramp-up and silver price movements, while operational disruptions and commodity volatility remain key risks for investors.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXK
99% Buy1% Sell
Avg holding period · 26 Days
KYMR
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Endeavour Silver Corp

Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.

Read more on EXK →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →